Femto-LASIK outperformed

Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).

Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).

Richard J. Duffey, MD of Premier Medical Eye Group, Alabama, US compared flap thickness predictability, speed of visual recovery, higher order aberrations, smoothness of stromal bed and patient comfort between the two techniques. Dr Duffey has no financial interest in Moria or the One Use-Plus SBK.

For every variable, the One Use-Plus compared equally or favourably with Femto-LASIK, with none of the associated complications of the latter device. Postoperative pain in the first one to five hours was lower in both frequency and intensity when using the One Use-Plus than with Femto-LASIK.

Dr Duffey concluded that the One Use-Plus was a better option for both patients and surgeons than Femto-LASIK.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
© 2023 MJH Life Sciences

All rights reserved.